The ROADSTER 2 Study is a follow up to the ROADSTER Study, which evaluated the TCAR Procedure in 141 patients at high risk for complications from surgery. The results from the ROADSTER Study were published in the Journal of Vascular Surgery in November 2015.

The ROADSTER 2 Study is underway and seeks to enroll 600+ patients to be treated with the TCAR Procedure using the ENROUTE® Transcarotid Neuroprotection and ENROUTE® Transcarotid Stent System. If you or someone you know have been diagnosed with carotid artery disease and you would like to see if the ROADSTER 2 Study is an option for you, contact Silk Road Medical at

For more detailed information about ROADSTER 2, please visit the study page at